TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Jiangsu Recbio Technology Co., Ltd. Class H ( (HK:2179) ) just unveiled an update.
Jiangsu Recbio Technology Co., Ltd. has announced a board meeting scheduled for August 29, 2025, to consider and approve the unaudited interim results for the six months ending June 30, 2025, and to discuss the potential payment of an interim dividend. This meeting is significant as it will provide insights into the company’s financial health and strategic decisions, potentially impacting shareholder value and market perception.
More about Jiangsu Recbio Technology Co., Ltd. Class H
Jiangsu Recbio Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the biotechnology industry. The company focuses on developing and providing innovative biotechnological solutions and products.
Average Trading Volume: 128,648
Technical Sentiment Signal: Sell
Current Market Cap: HK$3.71B
See more data about 2179 stock on TipRanks’ Stock Analysis page.